Transplantation of single-donor purified canine islets to the spleen or renal subcapsular space with cyclosporine immunosuppression.

PubWeight™: 0.76‹?›

🔗 View Article (PMID 2495671)

Published in Transplant Proc on February 01, 1989

Authors

M S Cattral1, G L Warnock, N M Kneteman, R V Rajotte

Author Affiliations

1: Department of Surgery, University of Alberta, Edmonton, Canada.

Articles citing this

The Diabetic Dog as a Translational Model for Human Islet Transplantation
. Yale J Biol Med (2017) 0.75

Articles by these authors

Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med (2000) 18.26

Hepatitis C virus replication in mice with chimeric human livers. Nat Med (2001) 5.87

Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo. Hepatology (1996) 2.94

Islet isolation assessment in man and large animals. Acta Diabetol Lat (1991) 2.89

Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes (2001) 2.51

High risk of sensitization after failed islet transplantation. Am J Transplant (2007) 2.29

Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Liver Transpl Surg (1997) 2.16

Normoglycaemia after transplantation of freshly isolated and cryopreserved pancreatic islets in type 1 (insulin-dependent) diabetes mellitus. Diabetologia (1991) 2.15

Serine-protease inhibition during islet isolation increases islet yield from human pancreases with prolonged ischemia. Transplantation (2001) 1.54

Glucose-dependent insulin release from genetically engineered K cells. Science (2000) 1.52

Impaired proinsulin processing is a characteristic of transplanted islets. Am J Transplant (2009) 1.48

Large scale isolation, growth, and function of porcine neonatal islet cells. J Clin Invest (1996) 1.46

Islet amyloid deposition limits the viability of human islet grafts but not porcine islet grafts. Proc Natl Acad Sci U S A (2010) 1.45

Cytotoxic effects of cytokines on human pancreatic islet cells in monolayer culture. J Clin Endocrinol Metab (1990) 1.44

Variables in organ donors that affect the recovery of human islets of Langerhans. Transplantation (1996) 1.33

Intraductal collagenase delivery into the human pancreas using syringe loading or controlled perfusion. Cell Transplant (1999) 1.31

Revelation of specificity of 64K autoantibodies in IDDM serums by high-resolution 2-D gel electrophoresis. Unambiguous identification of 64K target antigen. Diabetes (1989) 1.30

Cotransplantation of allogeneic islets with allogeneic testicular cell aggregates allows long-term graft survival without systemic immunosuppression. Diabetes (1997) 1.29

Left paraduodenal hernia: an unusual cause of small-bowel obstruction. Can J Surg (2001) 1.29

Transfection of human pancreatic islets with an anti-apoptotic gene (bcl-2) protects beta-cells from cytokine-induced destruction. Diabetes (1999) 1.25

IFN-gamma alters the pathology of graft rejection: protection from early necrosis. J Immunol (2001) 1.25

Immunohistochemical characterisation of cells co-producing insulin and glucagon in the developing human pancreas. Diabetologia (2011) 1.23

Prevention of bleeding after islet transplantation: lessons learned from a multivariate analysis of 132 cases at a single institution. Am J Transplant (2005) 1.23

A brief history of endoscopy, laparoscopy, and laparoscopic surgery. J Laparoendosc Adv Surg Tech A (1997) 1.18

Does volume of clinical experience affect performance of clinical clerks on surgery exit examinations? Am J Surg (1996) 1.17

Problem-based learning: its role in undergraduate surgical education. Can J Surg (1995) 1.14

Rapid resolution of chylous ascites after liver transplantation using somatostatin analog and total parenteral nutrition. Transplantation (1996) 1.11

Portal vein thrombosis is a potentially preventable complication in clinical islet transplantation. Am J Transplant (2011) 1.10

Critical mass of purified islets that induce normoglycemia after implantation into dogs. Diabetes (1988) 1.10

Prevention of recurrence of IDDM in islet-transplanted diabetic NOD mice by adjuvant immunotherapy. Diabetes (1992) 1.09

Human pancreas preservation prior to islet isolation. Cold ischemic tolerance. Transplantation (1995) 1.09

Basal expression of cyclooxygenase-2 and nuclear factor-interleukin 6 are dominant and coordinately regulated by interleukin 1 in the pancreatic islet. Proc Natl Acad Sci U S A (1998) 1.06

Long-term follow-up after transplantation of insulin-producing pancreatic islets into patients with type 1 (insulin-dependent) diabetes mellitus. Diabetologia (1992) 1.06

Continued function of pancreatic islets after transplantation in type I diabetes. Lancet (1989) 1.05

Human pancreatic islet beta-cell destruction by cytokines involves oxygen free radicals and aldehyde production. J Clin Endocrinol Metab (1996) 1.04

Studies of the isolation and viability of human islets of Langerhans. Transplantation (1988) 1.03

Performance of subcutaneously implanted needle-type glucose sensors employing a novel trilayer coating. Anal Chem (1993) 1.02

Interferon-gamma acts directly on rejecting renal allografts to prevent graft necrosis. Am J Pathol (2001) 1.00

TRAIL-engineered pancreas-derived mesenchymal stem cells: characterization and cytotoxic effects on pancreatic cancer cells. Cancer Gene Ther (2012) 1.00

Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Transplantation (1998) 1.00

Diabetes induces rapid suppression of adaptive immunity followed by homeostatic T-cell proliferation. Scand J Immunol (2007) 1.00

Testicular sertoli cells protect islet beta-cells from autoimmune destruction in NOD mice by a transforming growth factor-beta1-dependent mechanism. Diabetes (2000) 1.00

Human pancreatic islet beta-cell destruction by cytokines is independent of nitric oxide production. J Clin Endocrinol Metab (1994) 0.98

Critical mass of islets that function after implantation in a large mammalian. Horm Metab Res Suppl (1990) 0.97

Osmotic behavior and transport properties of human islets in a dimethyl sulfoxide solution. Cryobiology (1997) 0.96

In vitro and in vivo expression of Galalpha-(1,3)Gal on porcine islet cells is age dependent. J Endocrinol (2003) 0.95

High yield of rodent islets with intraductal collagenase and stationary digestion--a comparison with standard technique. Cell Transplant (1997) 0.95

Peroxynitrite is a mediator of cytokine-induced destruction of human pancreatic islet beta cells. Lab Invest (2001) 0.94

Isolation of viable islets of Langerhans from collagenase-perfused canine and human pancreata. Transplant Proc (1987) 0.94

The glucagon-like peptide-1 receptor agonist exenatide restores impaired pro-islet amyloid polypeptide processing in cultured human islets: implications in type 2 diabetes and islet transplantation. Diabetologia (2012) 0.93

Risk for developing type 1 (insulin-dependent) diabetes mellitus and the presence of islet 64K antibodies. Diabetologia (1991) 0.93

Successful autotransplantation of isolated islets of Langerhans in the cynomolgus monkey. Br J Surg (1986) 0.93

Portal vein thrombosis after transplantation of partially purified pancreatic islets in a combined human liver/islet allograft. Transplantation (1995) 0.93

Combined therapy with interleukin-4 and interleukin-10 inhibits autoimmune diabetes recurrence in syngeneic islet-transplanted nonobese diabetic mice. Analysis of cytokine mRNA expression in the graft. Transplantation (1995) 0.93

Survival and function of purified islets in the omental pouch site of outbred dogs. Transplantation (1993) 0.93

Deletion of Fas protects islet beta cells from cytotoxic effects of human islet amyloid polypeptide. Diabetologia (2012) 0.93

Normoglycemia after implantation of purified islet cells in dogs. Can J Surg (1988) 0.92

Efficacy of lamivudine in chronic hepatitis B patients with active viral replication and decompensated cirrhosis undergoing liver transplantation. Transplantation (1996) 0.92

Musashi expression in β-cells coordinates insulin expression, apoptosis and proliferation in response to endoplasmic reticulum stress in diabetes. Cell Death Dis (2011) 0.92

Novel approaches toward early diagnosis of islet allograft rejection. Transplantation (2001) 0.91

Isolation and quantification of canine islet tissue for transplantation. Transplantation (1987) 0.91

Differences between amyloid toxicity in alpha and beta cells in human and mouse islets and the role of caspase-3. Diabetologia (2010) 0.91

Beta-cell destruction in NOD mice correlates with Fas (CD95) expression on beta-cells and proinflammatory cytokine expression in islets. Diabetes (1999) 0.90

Viable purified islets of Langerhans from collagenase-perfused human pancreas. Diabetes (1989) 0.90

In vitro and in vivo performance and lifetime of perfluorinated ionomer-coated glucose sensors after high-temperature curing. Anal Chem (1994) 0.89

Testicular Sertoli cells exert both protective and destructive effects on syngeneic islet grafts in non-obese diabetic mice. Diabetologia (2000) 0.89

Graft-versus-host disease after liver transplantation complicated by systemic aspergillosis with pancarditis. Can J Gastroenterol (2000) 0.89

Insulin resistance and impaired glucose tolerance in the atherosclerosis-prone LA/N corpulent rat. Arteriosclerosis (1988) 0.88

Genetically engineered Sertoli cells are able to survive allogeneic transplantation. Gene Ther (2004) 0.88

Islet cryopreservation using intracellular preservation solutions. Cell Transplant (2001) 0.87

The isolation of purified human islets of Langerhans. Transplant Proc (1987) 0.87

In vivo characterization of transplanted human embryonic stem cell-derived pancreatic endocrine islet cells. Cell Prolif (2008) 0.87